Aminocaproic Acid
Back to searchMolecule Structure
Scientific Name
Aminocaproic Acid
Description of the Drug
Aminocaproic acid is an antifibrinolytic agent used to induce clotting postoperatively.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00513
http://www.drugbank.ca/drugs/DB00513
Brand Name(s)
Amicar, Aminocaproic, Aminocaproic acid, Epsikapron
Company Owner(s)
Tulex Pharmaceuticals Inc, Amneal Pharmaceuticals Llc, Msn Laboratories Private Ltd, Luitpold Pharmaceuticals Inc, Sunny Pharmtech Inc, Baxter Healthcare Corp Anesthesia And Critical Care, Carnegie Pharmaceuticals Llc, Agenix Pharmaceuticals Llc, Abraxis Pharmaceutical Products, Hospira Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tissue-type plasminogen activator | SINGLE PROTEIN | INHIBITOR | CHEMBL1873 |
| Plasminogen | SINGLE PROTEIN | INHIBITOR | CHEMBL1801 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15293 | |||||||||||
| PharmGKB | PA164774947 | |||||||||||
| Human Metabolome Database | HMDB0001901 | |||||||||||
| DrugBank | DB00513 | |||||||||||
| PubChem: Thomson Pharma | 15119949 | |||||||||||
| PubChem | 517030 | 564 | ||||||||||
| Mcule | MCULE-3640363033 | |||||||||||
| NMRShiftDB | 10008873 | |||||||||||
| LINCS | LSM-5733 | |||||||||||
| Nikkaji | J1.398F | |||||||||||
| PDBe | ACA | |||||||||||
| BindingDB | 50357211 | |||||||||||
| EPA CompTox Dashboard | DTXSID0020070 | |||||||||||
| LipidMaps | LMFA01100035 | |||||||||||
| DrugCentral | 163 | |||||||||||
| Metabolights | MTBLC16586 | MTBLC57826 | ||||||||||
| Brenda | 5542 | 44105 | 31313 | 2718 | 93331 | 2822 | 20060 | 35816 | 155197 | 113362 | 29626 | 120669 |
| Rhea | 57826 | |||||||||||
| ChemicalBook | CB5223888 | CB11455952 | ||||||||||
| Guide to Pharmacology | 6574 | |||||||||||
| rxnorm | AMICAR | 6-AMINOCAPROIC ACID | AMINOCAPROATE | |||||||||
| KEGG Ligand | C02378 | |||||||||||
| ChEBI | 16586 | 57826 | ||||||||||
| ZINC | ZINC000001529425 |
